Results 21 to 30 of about 67,102 (251)

The importance of iron in long-term survival of maintenance hemodialysis patients treated with epoetin-alfa and intravenous iron: analysis of 9.5 years of prospectively collected data

BMC Nephrology, 2009
Background In patients treated by maintenance hemodialysis the relationship to survival of hemoglobin level and administered epoetin-alfa and intravenous iron is controversial.
Shukla Rakesh, Lorch Jonathan A, Pollak Victor E, Satwah Supriya   +3 more
doaj   +1 more source

Intravenous versus oral iron supplementation for correction of post-transplant anaemia in renal transplant patients

BMC Nephrology, 2009
Background Post-transplant anaemia remains a common problem after kidney transplantation, with an incidence ranging from nearly 80% at day 0 to about 25% at 1 year.
Mudge David W, Tan Ken-Soon, Miles Rhianna, Johnson David W, Campbell Scott B, Hawley Carmel M, Isbel Nicole M, Van Eps Carolyn L, Nicol David L   +8 more
doaj   +1 more source

Studying the Intravenous Iron Sucrose in Antioxidant Status and Oxidative Stress in Pregnant Females with Iron Deficiency Anemia

Journal of Pharmacy and Bioallied Sciences
Background: Intravenous iron supplementation can pose a risk of producing free iron in circulation as free iron is well-established in generating the free radicals that have a role in oxidative stress that reduces IDA (iron deficiency anemia).
Sarika Rawat, Pooja Jain, Dolly Marawi, Varsha Rani Choudhary, Roshan Mandloi   +4 more
doaj   +1 more source

Efficacy of IV Iron Compared to Oral Iron for Increment of Haemoglobin Level in Anemic Chronic Kidney Disease Patients

Journal of Nepal Medical Association, 2011
Introduction: Anemia is the most common finding in chronic kidney disease patients. Iron supplements are commonly prescribed for these patients with or without erythropoietin therapy by means of oral and intravenous iron.
L Adhikary, S Acharya
doaj   +1 more source

Intravenous iron supplementation therapy

Molecular Aspects of Medicine, 2020
Intravenous infusions of iron have evolved from a poorly effective and dangerous intervention to a safe cornerstone in the treatment of iron deficiency. Modern iron formulations are composite nanoparticles composed of carbohydrate ferric oxy-hydroxides.
Benedikt, Schaefer, Eva, Meindl, Sonja, Wagner, Herbert, Tilg, Heinz, Zoller   +4 more
openaire   +2 more sources

Association of Elevated Platelets and C‐Reactive Protein With Severe Disease and Poor Survival in Systemic Sclerosis

Arthritis Care &Research, EarlyView.
Objective Elevated C‐reactive protein (CRP) levels in systemic sclerosis (SSc) have been linked with severe disease and worse survival, but the role of platelet levels remains unclear. This study examined whether elevated platelet levels, CRP levels, or both are associated with disease severity, progression, and survival in SSc.
Brian S. Lee, Shufeng Li, Srijana Davuluri, Jennifer Lee, Lorinda Chung   +4 more
wiley   +1 more source

Intravenous iron sucrose v/s oral ferrous fumarate for treatment of anemia in pregnancy. A randomized controlled trial

BMC Pregnancy and Childbirth, 2017
Background The objective of this study was to compare the efficacy, safety and tolerability of intravenous iron sucrose with that of oral ferrous fumarate in iron deficiency anemia during 14 to 34 weeks of pregnancy. Methods A randomized controlled trial
Shruti B. Bhavi, Purushottam B. Jaju
doaj   +1 more source

Fusogenic RNA Nanomodules for Fusion‐Mediated and Multiplexed siRNA Delivery

Advanced Functional Materials, EarlyView.
A fusogenic lipid‐layered RNA nanomodules (L‐CRAMs) enable high‐capacity and long‐lasting siRNA delivery through membrane fusion. These nanomodules carry exceptionally large siRNA payloads, avoid conventional endosomal uptake, and release multiple functional siRNAs through Dicer‐mediated processing.
Sunghyun Moon, Iksoo Jang, Taehyeon Kim, Nayoung Yoon, Kyuha Yum, Jong Bum Lee   +5 more
wiley   +1 more source

Beyond Detection

JACC: Case Reports
Background: Iron deficiency is a common comorbidity among patients with heart failure with reduced ejection fraction (HFrEF), and it remains under-recognized and undertreated despite contemporary guideline recommendations for intravenous iron therapy ...
Benjamin M. Easow, MD, Tijin Mathew, MD, Devesh Dahale, MS, MBA, Darius Aliabadi, MD   +3 more
doaj   +1 more source

Informing primi and elderly pregnant women about iron sucrose administration for moderate anemia can improve treatment compliance in public health facilities, Kancheepuram health district, Tamil Nadu, India, 2017: A cross-sectional study

Clinical Epidemiology and Global Health, 2021
Introduction: Tamil Nadu administers intravenous iron sucrose for correcting moderate anaemia among pregnant women (Haemoglobin level 7–8.9 g/dl) based on preliminary studies.
Anandan Mohan, Sakthivel Manikandanesan, Ponnaiah Manickam, Karumanagounder Kolandaswamy, Manoj Murhekar   +4 more
doaj   +1 more source